Low-dose emicizumab for more equitable access to prophylaxis in resource limited countries

Haemophilia. 2024 May;30(3):575-576. doi: 10.1111/hae.14968. Epub 2024 Feb 28.
No abstract available

Keywords: emicizumab; humanitarian aid program; low income countries.

Publication types

  • Letter

MeSH terms

  • Antibodies, Bispecific* / therapeutic use
  • Antibodies, Monoclonal, Humanized* / therapeutic use
  • Developing Countries
  • Health Services Accessibility
  • Hemophilia A* / drug therapy
  • Humans

Substances

  • emicizumab
  • Antibodies, Bispecific
  • Antibodies, Monoclonal, Humanized